P04

Non-Billable

Newborn affected by noxious substances transmitted via placenta or breast milk

P04 should not be used for reimbursement purposes as there are multiple sub-diagnoses that fall under this code. Please refer to the sub-diagnoses below.

Related Diagnoses

  • P04.0Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
  • P04.1Newborn affected by other maternal medication
    • P04.11Newborn affected by maternal antineoplastic chemotherapy
    • P04.12Newborn affected by maternal cytotoxic drugs
    • P04.13Newborn affected by maternal use of anticonvulsants
    • P04.14Newborn affected by maternal use of opiates
    • P04.15Newborn affected by maternal use of antidepressants
    • P04.16Newborn affected by maternal use of amphetamines
    • P04.17Newborn affected by maternal use of sedative-hypnotics
    • P04.1ANewborn affected by maternal use of anxiolytics
    • P04.18Newborn affected by other maternal medication
    • P04.19Newborn affected by maternal use of unspecified medication
  • P04.2Newborn affected by maternal use of tobacco
  • P04.3Newborn affected by maternal use of alcohol
  • P04.4Newborn affected by maternal use of drugs of addiction
    • P04.40Newborn affected by maternal use of unspecified drugs of addiction
    • P04.41Newborn affected by maternal use of cocaine
    • P04.42Newborn affected by maternal use of hallucinogens
    • P04.49Newborn affected by maternal use of other drugs of addiction
  • P04.5Newborn affected by maternal use of nutritional chemical substances
  • P04.6Newborn affected by maternal exposure to environmental chemical substances
  • P04.8Newborn affected by other maternal noxious substances
    • P04.81Newborn affected by maternal use of cannabis
    • P04.89Newborn affected by other maternal noxious substances
  • P04.9Newborn affected by maternal noxious substance, unspecified